Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes

By sjmartinez • November 30, 2024

Rhee CM, Gianchandani RY, Kerr D, Philis-Tsimikas A, Kovesdy CP, Stanton RC, Drincic AT, Galindo RJ, Kalantar-Zadeh K, Neumiller JJ, de Boer IH, Lind M, Kim SH, Ayers AT, Ho CN, Aaron RE, Tian T, Klonoff DC. Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes. J Diabetes Sci Technol. 2024 Nov 29:19322968241292041. doi: 10.1177/19322968241292041. Epub ahead of print. PMID: 39611379; PMCID: PMC11607725.

Tags: Cedars Sinai DoM, Chronic kidney disease, continuous glucose monitor, diabetes, diabetic kidney disease, dialysis, end-stage kidney disease, Endocrinology, Nephrology, Publications, Veterans Administration

Related Posts

Association of Eicosanoids and Eicosanoid-Related Metabolites With Obesity and Cardiometabolic Traits

Chitsazan M, Parekh JK, Grundmann AL, Lau ES, Alotaibi M, Yu B, Rebholz CM, Selvin E, Allen NB, Allison MA, Jain M, Cheng S, Ho[...]

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial

Baden LR, Shah NS, Liu STH, Cohen J, Moy J, Kumar A, McComsey GA, Chen P, Floris-Moore M, Singer NG, Fernandez I, Slandzicki AJ, Wiley[...]

L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial

Gong J, Muranaka H, Choi SY, Tighiouart M, Bhute S, Aja ER, Jacobs JP, Stotland A, Van Eyk J, Elmadbouh OHM, Edderkaoui M, Tanaka S,[...]